{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-25-004977","form_type":"8-K","ticker":"TNGX","cik":"0001819133","company_name":"Tango Therapeutics, Inc.","filed_at":"2025-01-13T23:59:59+00:00","discovered_at":"2026-05-14T18:03:05.046704+00:00","generated_at":"2026-05-28T03:46:10.279830+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"confidence":"high","headline":"Tango Therapeutics discloses $257.9M cash as of Dec 31, 2024","bullets":["Cash, cash equivalents and marketable securities totaled $257.9M (unaudited).","Company updated its corporate presentation for use with investors and analysts.","No other financial results or guidance were provided in this filing."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-25-004977","json":"https://secwatch.observer/filing/0001193125-25-004977.json","markdown":"https://secwatch.observer/filing/0001193125-25-004977.md","text":"https://secwatch.observer/filing/0001193125-25-004977.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1819133/000119312525004977/0001193125-25-004977-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1819133/000119312525004977/d917886d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-28T03:46:10.279830+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}